Massimiliano Camilli: Mechanistic Insights Into Cardiovascular Risk Across Androgen Deprivation Therapies
Massimiliano Camilli, Member of the Atrial Disorders Committee of the Heart Failure Association of the ESC at European Society of Cardiology, shared a post on LinkedIn about a recent article by Antonia Beitzen-Heineke et al, published in JACC: CardioOncology, adding:
“Why might cardiovascular risk differ across androgen deprivation therapies?
A new prospective study in JACC: CardioOncology provides interesting mechanistic insights into the cardiovascular effects of androgen deprivation therapy in patients with prostate cancer.
Patients with prostate cancer already showed a heightened platelet activation and thromboinflammatory profile compared with healthy controls.
Importantly, the two ADT strategies appeared to have different effects:
- Leuprolide was associated with further increases in platelet reactivity across multiple agonist pathways.
- Relugolix, in contrast, did not increase platelet activation and was associated with reduced arachidonic acid–induced P-selectin and CD40 expression, alongside down-regulation of transcriptomic pathways involved in platelet activation and aggregation.
These findings provide a potential biological framework for the differences in cardiovascular outcomes observed across GnRH-based therapies and further highlight the complex interplay between cancer treatment, thrombosis, and cardiovascular risk.
An important step toward better understanding how the choice of anticancer therapy may influence cardiovascular health in patients with prostate cancer.”
Title: Divergent Effects of GnRH Agonist and GnRH Antagonist Treatment on Platelet Activity and Transcriptome
Authors: Antonia Beitzen-Heineke, Matthew Siskin, Matthew Muller, Anshini Bhatt, Kathryn C. Hafertepe, Yuhe Xia, Minas Economides, David R. Wise, Jeffrey S. Berger

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 3, 2026, 02:21Digambar Panchal: NGS Demonstrates Key Role in Solving Challenging Hematology Cases at LTMGH
-
Nov 3, 2026, 02:07David Smadja: Does Immediate Breast Reconstruction Increase the Risk of Thrombosis and Bleeding after a Mastectomy?
-
Nov 3, 2026, 01:57Nour Al-Mozain: What Does a Bathtub Have to Do with Hemoglobin S?
-
Nov 3, 2026, 01:51Cesar de Almeida Neto: Highlighting The Final Day of Hemo 2026
-
Nov 3, 2026, 01:34Jae Hyun Byun: Beyond Stenosis Understanding Carotid Plaque Instability
-
Nov 3, 2026, 01:20Smriti Yadav: A New Milestone in Transfusion Medicine
-
Nov 3, 2026, 00:55Dušan Ušjak: A Month of Research and Scientific Collaboration
-
Nov 3, 2026, 00:27Grace Gorecki: Early IVIG Accelerates Platelet Recovery in HIT
-
Nov 2, 2026, 22:15Micheline Mambue: A Case of Early Stent Thrombosis Successfully Managed With Repeat Angioplasty